>AT5G52640.1 | ATHSP901 (HEAT SHOCK PROTEIN 901) ATP binding / unfolded protein binding
MADVQMADAETFAFQAEINQLLSLIINTFYSNKEIFLRELISNSSDALDKIRFESLTDKS
KLDGQPELFIRLVPDKSNKTLSIIDSGIGMTKADLVNNLGTIARSGTKEFMEALQAGADV
SMIGQFGVGFYSAYLVAEKVVVTTKHNDDEQYVWESQAGGSFTVTRDVDGEPLGRGTKIT
LFLKDDQLEYLEERRLKDLVKKHSEFISYPIYLWTEKTTEKEISDDEDEDEPKKENEGEV
EEVDEEKEKDGKKKKKIKEVSHEWELINKQKPIWLRKPEEITKEEYAAFYKSLTNDWEDH
LAVKHFSVEGQLEFKAILFVPKRAPFDLFDTRKKLNNIKLYVRRVFIMDNCEELIPEYLS
FVKGVVDSDDLPLNISRETLQQNKILKVIRKNLVKKCIEMFNEIAENKEDYTKFYEAFSK
NLKLGIHEDSQNRGKIADLLRYHSTKSGDEMTSFKDYVTRMKEGQKDIFYITGESKKAVE
NSPFLERLKKRGYEVLYMVDAIDEYAVGQLKEYDGKKLVSATKEGLKLEDETEEEKKKRE
EKKKSFENLCKTIKEILGDKVEKVVVSDRIVDSPCCLVTGEYGWTANMERIMKAQALRDS
SMSGYMSSKKTMEINPDNGIMEELRKRAEADKNDKSVKDLVMLLYETALLTSGFSLDEPN
TFAARIHRMLKLGLSIDEDENVEEDGDMPELEEDAAEESKMEEVD*
>AT3G03800.1 | SYP131 (SYNTAXIN OF PLANTS 131) SNAP receptor
MNDLLKGSLEFSRDRSNRSDIESGHGPGNSGDLGLSGFFKKVQEIEKQYEKLDKHLNKLQ
GAHEETKAVTKAPAMKSIKQRMERDVDEVGRISRFIKGKIEELDRENLENRTKPGCGKGT
GVDRTRTATTIAVKKKFKDKISEFQTLRQNIQQEYREVVERRVFTVTGQRADEEAIDRLI
ETGDSEQIFQKAIREQGRGQIMDTLAEIQERHDAVRDLEKKLLDLQQVFLDMAVLVDAQG
EMLDNIENMVSSAVDHVQSGNNQLTKAVKSQKSSRKWMCIAILILLIIIIITVISVLKPW
TQKNGA*
>AT2G33120.1 | SAR1 (SYNAPTOBREVIN-RELATED PROTEIN 1)
MAQQSLIYSFVARGTVILVEFTDFKGNFTSIAAQCLQKLPSSNNKFTYNCDGHTFNYLVE
NGFTYCVVAVDSAGRQIPMAFLERVKEDFNKRYGGGKAATAQANSLNKEFGSKLKEHMQY
CMDHPDEISKLAKVKAQVSEVKGVMMENIEKVLDRGEKIELLVDKTENLRSQAQDFRTQG
TQMRRKMWFQNMKIKLIVLAIIIALILIIILSICGGFNCGK*
>AT2G33120.1 | SAR1 (SYNAPTOBREVIN-RELATED PROTEIN 1)
MAQQSLIYSFVARGTVILVEFTDFKGNFTSIAAQCLQKLPSSNNKFTYNCDGHTFNYLVE
NGFTYCVVAVDSAGRQIPMAFLERVKEDFNKRYGGGKAATAQANSLNKEFGSKLKEHMQY
CMDHPDEISKLAKVKAQVSEVKGVMMENIEKVLDRGEKIELLVDKTENLRSQAQDFRTQG
TQMRRKMWFQNMKIKLIVLAIIIALILIIILSICGGFNCGK*
>AT2G33120.2 | SAR1 (SYNAPTOBREVIN-RELATED PROTEIN 1)
MAQQSLIYSFVARGTVILVEFTDFKGNFTSIAAQCLQKLPSSNNKFTYNCDGHTFNYLVE
NGFSESKYCSISYCVVAVDSAGRQIPMAFLERVKEDFNKRYGGGKAATAQANSLNKEFGS
KLKEHMQYCMDHPDEISKLAKVKAQVSEVKGVMMENIEKVLDRGEKIELLVDKTENLRSQ
AQDFRTQGTQMRRKMWFQNMKIKLIVLAIIIALILIIILSICGGFNCGK*
>AT2G33120.2 | SAR1 (SYNAPTOBREVIN-RELATED PROTEIN 1)
MAQQSLIYSFVARGTVILVEFTDFKGNFTSIAAQCLQKLPSSNNKFTYNCDGHTFNYLVE
NGFSESKYCSISYCVVAVDSAGRQIPMAFLERVKEDFNKRYGGGKAATAQANSLNKEFGS
KLKEHMQYCMDHPDEISKLAKVKAQVSEVKGVMMENIEKVLDRGEKIELLVDKTENLRSQ
AQDFRTQGTQMRRKMWFQNMKIKLIVLAIIIALILIIILSICGGFNCGK*
>AT1G12360.1 | KEU (keule) protein transporter
MSYSDSDSSSHGGEYKNFRQITRERLLYEMLRSAKTGSSKSTWKVLIMDKLTVKIMSYAC
KMADITQEGVSLVEDIFRRRQPLPSMDAIYFIQPTKENVIMFLSDMSGKSPLYKKAFVFF
SSPVSKELVGHIKKDSSVLPRIGALREMNLEFFAIDSQGFITDHERALEDLFGDEETSRK
GDACLNVMASRIATVFASLREFPAVRYRAAKSLDASTMTTLRDLIPTKLAAGIWNCLAKH
KQSIENFPQTETCELLILDRSIDQIAPVIHEWTYDAMCHDLLNMEGNKYVHVIPSKSGGQ
PEKKDVLLEEHDPIWLELRHAHIADASERLHDKMTNFLSKNKAAQLQGKRDGAELSTRDL
QKMVQALPQYSEQIDKLSLHVEIARKLNDLIREQGLRELGQLEQDLVFGDAGMKDVIKYL
STQEEASREGKLRLLMILATIYPEKFEGEKGQNLMKLAKLSSDDMTAVNNMSLLGSAVDA
KKNTPGGFTLKFDLHKKKRAVRKERQEEAAWQLSRFYPMIEELIEKLSKGELPKEDFPCM
NDPSPSFHGSTSLSSAASSSQGQAAQSMRSRRTPTWAKPRGSDDGYSSDSVLRHASSDFR
KMGQRIFVFIVGGATRSELKVCHKLSTKLKREVILGSTSLDDPPQFITKLKLLTANDDLS
LDDLQI*
>AT1G59820.1 | ALA3 (Aminophospholipid ATPase3) ATPase coupled to transmembrane movement of ions phosphorylative mechanism / phospholipid transporter
MVRSGSFSVDSSATHQRTPSRTVTLGHIQPQAPTYRTVYCNDRESNQPVRFKGNSISTTK
YNVFTFLPKGLFEQFRRIANIYFLGISCLSMTPISPVSPITNVAPLSMVLLVSLIKEAFE
DWKRFQNDMSINNSTVEILQDQQWVSIPWRKLQVGDIVKIKKDGFFPADILFMSSTNSDG
ICYVETANLDGETNLKIRKALERTWDYLVPEKAYEFKGEIQCEQPNNSLYTFTGNLVVQK
QTLPLSPDQLLLRGCSLRNTEYIVGAVVFTGHETKVMMNAMNAPSKRSTLEKKLDKLIIT
IFCVLVTMCLIGAIGCSIVTDREDKYLGLHNSDWEYRNGLMIGFFTFFTLVTLFSSIIPI
SLYVSIEMIKFIQSTQFINRDLNMYHAETNTPASARTSNLNEELGQVEYIFSDKTGTLTR
NLMEFFKCSIGGVSYGCGVTEIEKGIAQRHGLKVQEEQRSTGAIREKGFNFDDPRLMRGA
WRNEPNPDLCKELFRCLAICHTVLPEGDESPEKIVYQAASPDEAALVTAAKNFGFFFYRR
TPTMVYVRESHVEKMGKIQDVAYEILNVLEFNSTRKRQSVVCRFPDGRLVLYCKGADNVI
FERLANGMDDVRKVTREHLEHFGSSGLRTLCLAYKDLNPETYDSWNEKFIQAKSALRDRE
KKLDEVAELIEKDLILIGSTAIEDKLQEGVPTCIETLSRAGIKIWVLTGDKMETAINIAY
ACNLINNEMKQFVISSETDAIREAEERGDQVEIARVIKEEVKRELKKSLEEAQHSLHTVA
GPKLSLVIDGKCLMYALDPSLRVMLLSLSLNCTSVVCCRVSPLQKAQVTSLVRKGAQKIT
LSIGDGANDVSMIQAAHVGIGISGMEGMQAVMASDFAIAQFRFLTDLLLVHGRWSYLRIC
KVVMYFFYKNLTFTLTQFWFTFRTGFSGQRFYDDWFQSLFNVVFTALPVIVLGLFEKDVS
ASLSKRYPELYREGIRNSFFKWRVVAVWATSAVYQSLVCYLFVTTSSFGAVNSSGKVFGL
WDVSTMVFTCLVIAVNVRILLMSNSITRWHYITVGGSILAWLVFAFVYCGIMTPHDRNEN
VYFVIYVLMSTFYFYFTLLLVPIVSLLGDFIFQGVERWFFPYDYQIVQEIHRHESDASKA
DQLEVENELTPQEARSYAISQLPRELSKHTGFAFDSPGYESFFASQLGIYAPQKAWDVAR
RASMRSRPKVPKK*
>AT5G23630.1 | ATPase E1-E2 type family protein / haloacid dehalogenase-like hydrolase familiy protein
MSSFRVGGKVVEKVDLCRKKQLVWRLDVWPFAILYTVWLTTIVPSIDFSDACIALGGLSA
FHILVLLFTTWSVDFKCFVQFSKVNSIDQADACKVTPAKFSGSKEVVPLHFRSQMTDSAS
SGDMEEIFFDFRKQRFIYSKELGAFSKLPYPTKETFGHYLKCTGHGTEAKIATATEKWGR
NVFDYPQPTFQKLMKENCMEPFFVFQVFCVGLWCLDEFWYYSVFTLFMLFMFESTMAKSR
LKTLTDLRSVRVDSQTVMVYRSGKWVKLLGTDLLPGDVVSIGRPSTQTGGEDKTVPADML
LLVGSAIVNEAILTGESTPQWKVPIVGQRSDEKLSIKRNKNHVLFGGTKILQHSPDKSFS
LKTPDGGCLAVVLRTGFETSQGKLMRTILFSTERVTANSWESGLFILFLVVFAVIAAGYV
LVKGLEDPTRSKYKLLLGCSLIITSVIPPELPMELSIAVNTSLLALVRRGIFCTEPFRIP
FAGKVDLCCFDKTGTLTSDDMEFRGVGGLSNCEEAETDMSKVPVRTLEILASCHALVFVE
NKLVGDPLEKAALKGIDWSYKADEKALPRRGNGNSVQIMQRYHFASHLKRMSVIVRIQEE
YLAFVKGAPETIQERLVDVPAQYIETYKRYTRQGSRVLALAYKRLPDMMVSEARDMDRDA
VESDLTFAGFAVFNCPIRPDSAPVLLELKNSSHDLVMITGDQALTACHVAGQVHIVSNPV
LILGRSGSGNEYKWVSPDEKEIIPYSEKEIETLAETHDLCIGGDSIEMLQATSAVLRVIP
FVKVFARVAPQQKELILTTFKAVGRGTLMCGDGTNDVGALKQAHVGVALLNNKLPLSPSD
SSKDDKSKSKKSKLPLEPASKTITQNGEGSSKGKIPPQNRHLTAAELQRQKLKKIMDDLN
NDEGDGRSAPLVKLGDASMASPFTAKHASVAPVTDIIRQGRSTLVTTLQMFKILGLNCLA
TAYVLSVMYLDGVKLGDVQATISGVLTAAFFLFISHARPLQTLSAERPHPSVFSVYLFLS
LIGQFAVHLTFLVYSVKEAEKHMPEECIEPDASFHPNLVNTVSYMVSMMLQVATFAVNYM
GHPFNQSIRENKPFFYALIAGAGFFTVIASDLFRDLNDSLKLVPLPQGLRDKLLIWASLM
FIICYSWERLLRWAFPGKISSWKHKQRAVTANLEKKKKV*
>AT4G03330.1 | SYP123 (SYNTAXIN OF PLANTS 123) SNAP receptor
MNDLISSSFKRYTDLNHQVQLDDIESQNVSLDSGNLDEFFGYVESVKEDMKAVDEIHKRL
QDANEESKTVHDSKAVKKLRARMDSSVTEVLKRVKMIKTKLVALEKSNAAQRKVAGCGPG
SSADRTRTSVVSGLGKKLKDMMDDFQRLRTKMATEYKETVERRYFTVTGQKADEETVEKL
ISSGESERFLQKAIQEQGRGQVMDTLSEIQERHDTVKEIERSLLELHQVFLDMAALVEAQ
GNMLNDIESNVSKASSFVMRGTDQLHGAKVLQRNNRKWACIATILAIVVVIVILFPILFN
TLLRP*
>AT4G35020.1 | ARAC3 (ARABIDOPSIS RAC-LIKE 3) GTP binding / GTPase
MSASRFIKCVTVGDGAVGKTCLLISYTSNTFPTDYVPTVFDNFSANVIVDGNTINLGLWD
TAGQEDYNRLRPLSYRGADVFLLAFSLVSKASYENVSKKWVPELRHYAPGVPIILVGTKL
DLRDDKQFFAEHPGAVPISTAQGEELKKLIGAPAYIECSAKTQQNVKAVFDAAIKVVLQP
PKNKKKKKRKSQKGCSIL*
>AT4G01320.1 | ATSTE24 endopeptidase/ metalloendopeptidase
MAIPFMETVVGFMIVMYIFETYLDLRQLTALKLPTLPKTLVGVISQEKFEKSRAYSLDKS
YFHFVHEFVTILMDSAILFFGILPWFWKMSGAVLPRLGLDPENEILHTLSFLAGVMTWSQ
ITDLPFSLYSTFVIESRHGFNKQTIWMFIRDMIKGTFLSVILGPPIVAAIIFIVQKGGPY
LAIYLWAFMFILSLVMMTIYPVLIAPLFNKFTPLPDGDLREKIEKLASSLKFPLKKLFVV
DGSTRSSHSNAYMYGFFKNKRIVLYDTLIQQCKNEDEIVAVIAHELGHWKLNHTTYSFIA
VQILAFLQFGGYTLVRNSTDLFRSFGFDTQPVLIGLIIFQHTVIPLQHLVSFGLNLVSRA
FEFQADAFAVKLGYAKDLRPALVKLQEENLSAMNTDPLYSAYHYSHPPLVERLRAIDGED
KKTD*
>AT1G67730.1 | YBR159 ketoreductase/ oxidoreductase
MEICTYFKSQPTWLLILFVLGSISIFKFIFTLLRSFYIYFLRPSKNLRRYGSWAIITGPT
DGIGKAFAFQLAQKGLNLILVARNPDKLKDVSDSIRSKYSQTQILTVVMDFSGDIDEGVK
RIKESIEGLDVGILINNAGMSYPYAKYFHEVDEELINNLIKINVEGTTKVTQAVLPNMLK
RKKGAIINMGSGAAALIPSYPFYSVYAGAKTYVDQFTKCLHVEYKKSGIDVQCQVPLYVA
TKMTKIRRASFLVASPEGYAKAALRFVGYEAQCTPYWPHALMGAVVSALPESVFESFNIK
RCLQIRKKGLQKDSMKKE*
>AT1G69640.1 | SBH1 (SPHINGOID BASE HYDROXYLASE 1) catalytic/ sphingosine hydroxylase
MMMGFAVSDELLGTVAPIVVYWLYSGIYVALSSLESYRLHSKVEEEEKNLVSKSSVVKGV
LVQQVVQAVVAILLFTVTGSDAEADKAQQFSFLVLARQFVTAMIVLDTWQYFMHRYMHQN
KFLYKHIHSQHHRLIVPYAYGALYNHPVEGLLLDTIGGALSFLVSGMSPRTSIFFFSFAT
IKTVDDHCGLWLPGNLFHMVFKNNSAYHDIHHQLYGTKYNFSQPFFVMWDRILGTYMPYS
LEKREDGGFEARPTKEFKDD*
>AT2G01600.1 | epsin N-terminal homology (ENTH) domain-containing protein
MGTLQSWRKAYGALKDSTKVGLVRVNSEYADLDVAIVKATNHVECPPKDRHLRKIFAATS
VTRARADVAYCIHALSRRLHKTRNWTVALKTLIVIHRLLREGDPTFREELLNFSQRGRIL
QLSNFKDDSSPIAWDCSAWVRTYALFLEERLECFRVLKYDTEAERLPKSNPGQDKGYSRT
RDLDGEELLEQLPALQQLLYRLIGCRPEGAANHNHVIQYALALVLKESFKVYCAINDGII
NLIDKFFEMAKHEAITSLEIYKRAGQQARSLSDFYEACKGLELARNFQFPVLREPPQSFL
TTMEEYIKEAPRVVDVPAEPLLLTYRPDDGLTTEDTEPSHEEREMLPSDDVVVVSEETEP
SPPPPPSANAQNFIDTDDLWGLNTGAPDTSVIEDQNALALAIVSTDADPPTPHFGQPNNY
DPTGWELALVTAPSSDISASTERKLAGGLDTLTLSSLYDDGAYIASQRPVYGAPAPNPFA
SHDPFASSNGTAPPPQQQAVNNPFGAYQQTYQHQPQPTYQHQSNPPTNNSNPFGDFGEFP
VNPVSQQPNTSGYGDFSVNQHNNPFRSTGLI*
>AT1G21170.1 | SEC5B
MSSSDDLDEDELLQMALKEQSQRDVTYQKPPSANSRKPVTNLVQQPRRQKRAAAPPSKGG
AKASRKPSMDEDDESEVELLSISSGDEDEGNDRGRGGGGDGGGGRGRGGSGKERGRARKE
DDRAWDGVEPDCWKRVNEAELARKVRDMRESRTAPSVTQNLDRKVSGADKKVVLTSLQSF
PRGMECIDPLKLGIIDNKTLRLITESSESLSKAEKVDNALREKLVYTSDHFDPKLFISRI
HQETSAADLESGALALKSDLKGRNLQRKQLVKDNFDCFVSCKTTIDDIESKLKRIEDDPD
GSGTTHLFNCMKSVTSRANRAFEPLFERQAQAEKIRSVQGMLQRFRTLFNLPSIIRSSIS
KGEYDLAVREYKKAKSIALPSHVNLLKRVLEEVEKVMQEFKGTLYRSMEDPKIDFTSLEN
TVRLLLELEPESDPVWHYLNVQNHRIHGMLEKCTFDHEARMEILRNQVHERALSDAKWRQ
IQQNGVQLSDDTSSMEDNQVQVDQPLEESARREKDALRGRYIKILTAVIVYHLPTFWKTA
LSVFTGKFAKSSQVNDTSASKAEEKAEEARYSSHSLEEIAGMIRNTISVYEAKVQSTFHD
FDESYILHPYMSDTIKEVSKACQAFEAKESAPHSAVMALRKVKVEITKIYIQRLCSWMRA
STEEISKEETWIPVSILERNRSPYSISYLPLAFRSIIVSGMEQINMMILSLKGEAARSED
MFAHIEEILISVRLAFLNCFLDFAAHLEQIGADLSQRTTKRESWQNGYSNDHQEEQSINA
PESVVDPHRQLLMILSNIGYCKDELASELYNKYKYTWLQSRRNDEDISDLQDLMMSFSGL
GEKVLEHYTFAKANLIRTAATNYLLDSGIQWGAAPPVKGIRDAAVELLHTLVAVHAEVFA
GAKPLLDKILGTLVEGLIDTFLSLLDENRSDDLSSIDANGFCQLMLELEYFETILKPYLT
VDATESLKSLQGAVLEKAIESISETVENNPGGHQRKPTRGSEDAISDDKQSSVSPDDLLA
LAQQCTSGMLQLELEKTRLNSACFIETIPLDPVPPVAKAAYSRTSTDSPSRNYRESQPMG
SPVQARPRRR*
>AT1G50030.1 | TOR (TARGET OF RAPAMYCIN) 1-phosphatidylinositol-3-kinase/ protein binding
MSTSSQSFVAGRPASMASPSQSHRFCGPSATASGGGSFDTLNRVIADLCSRGNPKEGAPL
AFRKHVEEAVRDLSGEASSRFMEQLYDRIANLIESTDVAENMGALRAIDELTEIGFGENA
TKVSRFAGYMRTVFELKRDPEILVLASRVLGHLARAGGAMTSDEVEFQMKTAFDWLRVDR
VEYRRFAAVLILKEMAENASTVFNVHVPEFVDAIWVALRDPQLQVRERAVEALRACLRVI
EKRETRWRVQWYYRMFEATQDGLGRNAPVHSIHGSLLAVGELLRNTGEFMMSRYREVAEI
VLRYLEHRDRLVRLSITSLLPRIAHFLRDRFVTNYLTICMNHILTVLRIPAERASGFIAL
GEMAGALDGELIHYLPTIMSHLRDAIAPRKGRPLLEAVACVGNIAKAMGSTVETHVRDLL
DVMFSSSLSSTLVDALDQITISIPSLLPTVQDRLLDCISLVLSKSHYSQAKPPVTIVRGS
TVGMAPQSSDPSCSAQVQLALQTLARFNFKGHDLLEFARESVVVYLDDEDAATRKDAALC
CCRLIANSLSGITQFGSSRSTRAGGRRRRLVEEIVEKLLRTAVADADVTVRKSIFVALFG
NQCFDDYLAQADSLTAIFASLNDEDLDVREYAISVAGRLSEKNPAYVLPALRRHLIQLLT
YLELSADNKCREESAKLLGCLVRNCERLILPYVAPVQKALVARLSEGTGVNANNNIVTGV
LVTVGDLARVGGLAMRQYIPELMPLIVEALMDGAAVAKREVAVSTLGQVVQSTGYVVTPY
KEYPLLLGLLLKLLKGDLVWSTRREVLKVLGIMGALDPHVHKRNQQSLSGSHGEVPRGTG
DSGQPIPSIDELPVELRPSFATSEDYYSTVAINSLMRILRDASLLSYHKRVVRSLMIIFK
SMGLGCVPYLPKVLPELFHTVRTSDENLKDFITWGLGTLVSIVRQHIRKYLPELLSLVSE
LWSSFTLPGPIRPSRGLPVLHLLEHLCLALNDEFRTYLPVILPCFIQVLGDAERFNDYTY
VPDILHTLEVFGGTLDEHMHLLLPALIRLFKVDAPVAIRRDAIKTLTRVIPCVQVTGHIS
ALVHHLKLVLDGKNDELRKDAVDALCCLAHALGEDFTIFIESIHKLLLKHRLRHKEFEEI
HARWRRREPLIVATTATQQLSRRLPVEVIRDPVIENEIDPFEEGTDRNHQVNDGRLRTAG
EASQRSTKEDWEEWMRHFSIELLKESPSPALRTCAKLAQLQPFVGRELFAAGFVSCWAQL
NESSQKQLVRSLEMAFSSPNIPPEILATLLNLAEFMEHDEKPLPIDIRLLGALAEKCRVF
AKALHYKEMEFEGPRSKRMDANPVAVVEALIHINNQLHQHEAAVGILTYAQQHLDVQLKE
SWYEKLQRWDDALKAYTLKASQTTNPHLVLEATLGQMRCLAALARWEELNNLCKEYWSPA
EPSARLEMAPMAAQAAWNMGEWDQMAEYVSRLDDGDETKLRGLASPVSSGDGSSNGTFFR
AVLLVRRAKYDEAREYVERARKCLATELAALVLESYERAYSNMVRVQQLSELEEVIEYYT
LPVGNTIAEERRALIRNMWTQRIQGSKRNVEVWQALLAVRALVLPPTEDVETWLKFASLC
RKSGRISQAKSTLLKLLPFDPEVSPENMQYHGPPQVMLGYLKYQWSLGEERKRKEAFTKL
QILTRELSSVPHSQSDILASMVSSKGANVPLLARVNLKLGTWQWALSSGLNDGSIQEIRD
AFDKSTCYAPKWAKAWHTWALFNTAVMSHYISRGQIASQYVVSAVTGYFYSIACAANAKG
VDDSLQDILRLLTLWFNHGATADVQTALKTGFSHVNINTWLVVLPQIIARIHSNNRAVRE
LIQSLLIRIGENHPQALMYPLLVACKSISNLRRAAAQEVVDKVRQHSGALVDQAQLVSHE
LIRVAILWHEMWHEALEEASRLYFGEHNIEGMLKVLEPLHDMLDEGVKKDSTTIQERAFI
EAYRHELKEAHECCCNYKITGKDAELTQAWDLYYHVFKRIDKQLASLTTLDLESVSPELL
LCRDLELAVPGTYRADAPVVTISSFSRQLVVITSKQRPRKLTIHGNDGEDYAFLLKGHED
LRQDERVMQLFGLVNTLLENSRKTAEKDLSIQRYSVIPLSPNSGLIGWVPNCDTLHHLIR
EHRDARKIILNQENKHMLSFAPDYDNLPLIAKVEVFEYALENTEGNDLSRVLWLKSRSSE
VWLERRTNYTRSLAVMSMVGYILGLGDRHPSNLMLHRYSGKILHIDFGDCFEASMNREKF
PEKVPFRLTRMLVKAMEVSGIEGNFRSTCENVMQVLRTNKDSVMAMMEAFVHDPLINWRL
FNFNEVPQLALLGNNNPNAPADVEPDEEDEDPADIDLPQPQRSTREKEILQAVNMLGDAN
EVLNERAVVVMARMSHKLTGRDFSSSAIPSNPIADHNNLLGGDSHEVEHGLSVKVQVQKL
INQATSHENLCQNYVGWCPFW*
>AT1G50030.1 | TOR (TARGET OF RAPAMYCIN) 1-phosphatidylinositol-3-kinase/ protein binding
MSTSSQSFVAGRPASMASPSQSHRFCGPSATASGGGSFDTLNRVIADLCSRGNPKEGAPL
AFRKHVEEAVRDLSGEASSRFMEQLYDRIANLIESTDVAENMGALRAIDELTEIGFGENA
TKVSRFAGYMRTVFELKRDPEILVLASRVLGHLARAGGAMTSDEVEFQMKTAFDWLRVDR
VEYRRFAAVLILKEMAENASTVFNVHVPEFVDAIWVALRDPQLQVRERAVEALRACLRVI
EKRETRWRVQWYYRMFEATQDGLGRNAPVHSIHGSLLAVGELLRNTGEFMMSRYREVAEI
VLRYLEHRDRLVRLSITSLLPRIAHFLRDRFVTNYLTICMNHILTVLRIPAERASGFIAL
GEMAGALDGELIHYLPTIMSHLRDAIAPRKGRPLLEAVACVGNIAKAMGSTVETHVRDLL
DVMFSSSLSSTLVDALDQITISIPSLLPTVQDRLLDCISLVLSKSHYSQAKPPVTIVRGS
TVGMAPQSSDPSCSAQVQLALQTLARFNFKGHDLLEFARESVVVYLDDEDAATRKDAALC
CCRLIANSLSGITQFGSSRSTRAGGRRRRLVEEIVEKLLRTAVADADVTVRKSIFVALFG
NQCFDDYLAQADSLTAIFASLNDEDLDVREYAISVAGRLSEKNPAYVLPALRRHLIQLLT
YLELSADNKCREESAKLLGCLVRNCERLILPYVAPVQKALVARLSEGTGVNANNNIVTGV
LVTVGDLARVGGLAMRQYIPELMPLIVEALMDGAAVAKREVAVSTLGQVVQSTGYVVTPY
KEYPLLLGLLLKLLKGDLVWSTRREVLKVLGIMGALDPHVHKRNQQSLSGSHGEVPRGTG
DSGQPIPSIDELPVELRPSFATSEDYYSTVAINSLMRILRDASLLSYHKRVVRSLMIIFK
SMGLGCVPYLPKVLPELFHTVRTSDENLKDFITWGLGTLVSIVRQHIRKYLPELLSLVSE
LWSSFTLPGPIRPSRGLPVLHLLEHLCLALNDEFRTYLPVILPCFIQVLGDAERFNDYTY
VPDILHTLEVFGGTLDEHMHLLLPALIRLFKVDAPVAIRRDAIKTLTRVIPCVQVTGHIS
ALVHHLKLVLDGKNDELRKDAVDALCCLAHALGEDFTIFIESIHKLLLKHRLRHKEFEEI
HARWRRREPLIVATTATQQLSRRLPVEVIRDPVIENEIDPFEEGTDRNHQVNDGRLRTAG
EASQRSTKEDWEEWMRHFSIELLKESPSPALRTCAKLAQLQPFVGRELFAAGFVSCWAQL
NESSQKQLVRSLEMAFSSPNIPPEILATLLNLAEFMEHDEKPLPIDIRLLGALAEKCRVF
AKALHYKEMEFEGPRSKRMDANPVAVVEALIHINNQLHQHEAAVGILTYAQQHLDVQLKE
SWYEKLQRWDDALKAYTLKASQTTNPHLVLEATLGQMRCLAALARWEELNNLCKEYWSPA
EPSARLEMAPMAAQAAWNMGEWDQMAEYVSRLDDGDETKLRGLASPVSSGDGSSNGTFFR
AVLLVRRAKYDEAREYVERARKCLATELAALVLESYERAYSNMVRVQQLSELEEVIEYYT
LPVGNTIAEERRALIRNMWTQRIQGSKRNVEVWQALLAVRALVLPPTEDVETWLKFASLC
RKSGRISQAKSTLLKLLPFDPEVSPENMQYHGPPQVMLGYLKYQWSLGEERKRKEAFTKL
QILTRELSSVPHSQSDILASMVSSKGANVPLLARVNLKLGTWQWALSSGLNDGSIQEIRD
AFDKSTCYAPKWAKAWHTWALFNTAVMSHYISRGQIASQYVVSAVTGYFYSIACAANAKG
VDDSLQDILRLLTLWFNHGATADVQTALKTGFSHVNINTWLVVLPQIIARIHSNNRAVRE
LIQSLLIRIGENHPQALMYPLLVACKSISNLRRAAAQEVVDKVRQHSGALVDQAQLVSHE
LIRVAILWHEMWHEALEEASRLYFGEHNIEGMLKVLEPLHDMLDEGVKKDSTTIQERAFI
EAYRHELKEAHECCCNYKITGKDAELTQAWDLYYHVFKRIDKQLASLTTLDLESVSPELL
LCRDLELAVPGTYRADAPVVTISSFSRQLVVITSKQRPRKLTIHGNDGEDYAFLLKGHED
LRQDERVMQLFGLVNTLLENSRKTAEKDLSIQRYSVIPLSPNSGLIGWVPNCDTLHHLIR
EHRDARKIILNQENKHMLSFAPDYDNLPLIAKVEVFEYALENTEGNDLSRVLWLKSRSSE
VWLERRTNYTRSLAVMSMVGYILGLGDRHPSNLMLHRYSGKILHIDFGDCFEASMNREKF
PEKVPFRLTRMLVKAMEVSGIEGNFRSTCENVMQVLRTNKDSVMAMMEAFVHDPLINWRL
FNFNEVPQLALLGNNNPNAPADVEPDEEDEDPADIDLPQPQRSTREKEILQAVNMLGDAN
EVLNERAVVVMARMSHKLTGRDFSSSAIPSNPIADHNNLLGGDSHEVEHGLSVKVQVQKL
INQATSHENLCQNYVGWCPFW*
>AT1G50030.2 | TOR (TARGET OF RAPAMYCIN) 1-phosphatidylinositol-3-kinase/ protein binding
MSTSSQSFVAGRPASMASPSQSHRFCGPSATASGGGSFDTLNRVIADLCSRGNPKEGAPL
AFRKHVEEAVRDLSGEASSRFMEQLYDRIANLIESTDVAENMGALRAIDELTEIGFGENA
TKVSRFAGYMRTVFELKRDPEILVLASRVLGHLARAGGAMTSDEVEFQMKTAFDWLRVDR
VEYRRFAAVLILKEMAENASTVFNVHVPEFVDAIWVALRDPQLQVRERAVEALRACLRVI
EKRETRWRVQWYYRMFEATQDGLGRNAPVHSIHGSLLAVGELLRNTGEFMMSRYREVAEI
VLRYLEHRDRLVRLSITSLLPRIAHFLRDRFVTNYLTICMNHILTVLRIPAERASGFIAL
GEMAGALDGELIHYLPTIMSHLRDAIAPRKGRPLLEAVACVGNIAKAMGSTVETHVRDLL
DVMFSSSLSSTLVDALDQITISIPSLLPTVQDRLLDCISLVLSKSHYSQAKPPVTIVRGS
TVGMAPQSSDPSCSAQVQLALQTLARFNFKGHDLLEFARESVVVYLDDEDAATRKDAALC
CCRLIANSLSGITQFGSSRSTRAGGRRRRLVEEIVEKLLRTAVADADVTVRKSIFVALFG
NQCFDDYLAQADSLTAIFASLNDEDLDVREYAISVAGRLSEKNPAYVLPALRRHLIQLLT
YLELSADNKCREESAKLLGCLVRNCERLILPYVAPVQKALVARLSEGTGVNANNNIVTGV
LVTVGDLARVGGLAMRQYIPELMPLIVEALMDGAAVAKREVAVSTLGQVVQSTGYVVTPY
KEYPLLLGLLLKLLKGDLVWSTRREVLKVLGIMGALDPHVHKRNQQSLSGSHGEVPRGTG
DSGQPIPSIDELPVELRPSFATSEDYYSTVAINSLMRILRDASLLSYHKRVVRSLMIIFK
SMGLGCVPYLPKVLPELFHTVRTSDENLKDFITWGLGTLVSIVRQHIRKYLPELLSLVSE
LWSSFTLPGPIRPSRGLPVLHLLEHLCLALNDEFRTYLPVILPCFIQVLGDAERFNDYTY
VPDILHTLEVFGGTLDEHMHLLLPALIRLFKVDAPVAIRRDAIKTLTRVIPCVQVTGHIS
ALVHHLKLVLDGKNDELRKDAVDALCCLAHALGEDFTIFIESIHKLLLKHRLRHKEFEEI
HARWRRREPLIVATTATQQLSRRLPVEVIRDPVIENEIDPFEEGTDRNHQVNDGRLRTAG
EASQRSTKEDWEEWMRHFSIELLKESPSPALRTCAKLAQLQPFVGRELFAAGFVSCWAQL
NESSQKQLVRSLEMAFSSPNIPPEILATLLNLAEFMEHDEKPLPIDIRLLGALAEKCRVF
AKALHYKEMEFEGPRSKRMDANPVAVVEALIHINNQLHQHEAAVGILTYAQQHLDVQLKE
SWYEKLQRWDDALKAYTLKASQTTNPHLVLEATLGQMRCLAALARWEELNNLCKEYWSPA
EPSARLEMAPMAAQAAWNMGEWDQMAEYVSRLDDGDETKLRGLASPVSSGDGSSNGTFFR
AVLLVRRAKYDEAREYVERARKCLATELAALVLESYERAYSNMVRVQQLSELEERIQGSK
RNVEVWQALLAVRALVLPPTEDVETWLKFASLCRKSGRISQAKSTLLKLLPFDPEVSPEN
MQYHGPPQVMLGYLKYQWSLGEERKRKEAFTKLQILTRELSSVPHSQSDILASMVSSKGA
NVPLLARVNLKLGTWQWALSSGLNDGSIQEIRDAFDKSTCYAPKWAKAWHTWALFNTAVM
SHYISRGQIASQYVVSAVTGYFYSIACAANAKGVDDSLQDILRLLTLWFNHGATADVQTA
LKTGFSHVNINTWLVVLPQIIARIHSNNRAVRELIQSLLIRIGENHPQALMYPLLVACKS
ISNLRRAAAQEVVDKVRQHSGALVDQAQLVSHELIRVAILWHEMWHEALEEASRLYFGEH
NIEGMLKVLEPLHDMLDEGVKKDSTTIQERAFIEAYRHELKEAHECCCNYKITGKDAELT
QAWDLYYHVFKRIDKQLASLTTLDLESVSPELLLCRDLELAVPGTYRADAPVVTISSFSR
QLVVITSKQRPRKLTIHGNDGEDYAFLLKGHEDLRQDERVMQLFGLVNTLLENSRKTAEK
DLSIQRYSVIPLSPNSGLIGWVPNCDTLHHLIREHRDARKIILNQENKHMLSFAPDYDNL
PLIAKVEVFEYALENTEGNDLSRVLWLKSRSSEVWLERRTNYTRSLAVMSMVGYILGLGD
RHPSNLMLHRYSGKILHIDFGDCFEASMNREKFPEKVPFRLTRMLVKAMEVSGIEGNFRS
TCENVMQVLRTNKDSVMAMMEAFVHDPLINWRLFNFNEVPQLALLGNNNPNAPADVEPDE
EDEDPADIDLPQPQRSTREKEILQAVNMLGDANEVLNERAVVVMARMSHKLTGRDFSSSA
IPSNPIADHNNLLGGDSHEVEHGLSVKVQVQKLINQATSHENLCQNYVGWCPFW*
>AT1G50030.2 | TOR (TARGET OF RAPAMYCIN) 1-phosphatidylinositol-3-kinase/ protein binding
MSTSSQSFVAGRPASMASPSQSHRFCGPSATASGGGSFDTLNRVIADLCSRGNPKEGAPL
AFRKHVEEAVRDLSGEASSRFMEQLYDRIANLIESTDVAENMGALRAIDELTEIGFGENA
TKVSRFAGYMRTVFELKRDPEILVLASRVLGHLARAGGAMTSDEVEFQMKTAFDWLRVDR
VEYRRFAAVLILKEMAENASTVFNVHVPEFVDAIWVALRDPQLQVRERAVEALRACLRVI
EKRETRWRVQWYYRMFEATQDGLGRNAPVHSIHGSLLAVGELLRNTGEFMMSRYREVAEI
VLRYLEHRDRLVRLSITSLLPRIAHFLRDRFVTNYLTICMNHILTVLRIPAERASGFIAL
GEMAGALDGELIHYLPTIMSHLRDAIAPRKGRPLLEAVACVGNIAKAMGSTVETHVRDLL
DVMFSSSLSSTLVDALDQITISIPSLLPTVQDRLLDCISLVLSKSHYSQAKPPVTIVRGS
TVGMAPQSSDPSCSAQVQLALQTLARFNFKGHDLLEFARESVVVYLDDEDAATRKDAALC
CCRLIANSLSGITQFGSSRSTRAGGRRRRLVEEIVEKLLRTAVADADVTVRKSIFVALFG
NQCFDDYLAQADSLTAIFASLNDEDLDVREYAISVAGRLSEKNPAYVLPALRRHLIQLLT
YLELSADNKCREESAKLLGCLVRNCERLILPYVAPVQKALVARLSEGTGVNANNNIVTGV
LVTVGDLARVGGLAMRQYIPELMPLIVEALMDGAAVAKREVAVSTLGQVVQSTGYVVTPY
KEYPLLLGLLLKLLKGDLVWSTRREVLKVLGIMGALDPHVHKRNQQSLSGSHGEVPRGTG
DSGQPIPSIDELPVELRPSFATSEDYYSTVAINSLMRILRDASLLSYHKRVVRSLMIIFK
SMGLGCVPYLPKVLPELFHTVRTSDENLKDFITWGLGTLVSIVRQHIRKYLPELLSLVSE
LWSSFTLPGPIRPSRGLPVLHLLEHLCLALNDEFRTYLPVILPCFIQVLGDAERFNDYTY
VPDILHTLEVFGGTLDEHMHLLLPALIRLFKVDAPVAIRRDAIKTLTRVIPCVQVTGHIS
ALVHHLKLVLDGKNDELRKDAVDALCCLAHALGEDFTIFIESIHKLLLKHRLRHKEFEEI
HARWRRREPLIVATTATQQLSRRLPVEVIRDPVIENEIDPFEEGTDRNHQVNDGRLRTAG
EASQRSTKEDWEEWMRHFSIELLKESPSPALRTCAKLAQLQPFVGRELFAAGFVSCWAQL
NESSQKQLVRSLEMAFSSPNIPPEILATLLNLAEFMEHDEKPLPIDIRLLGALAEKCRVF
AKALHYKEMEFEGPRSKRMDANPVAVVEALIHINNQLHQHEAAVGILTYAQQHLDVQLKE
SWYEKLQRWDDALKAYTLKASQTTNPHLVLEATLGQMRCLAALARWEELNNLCKEYWSPA
EPSARLEMAPMAAQAAWNMGEWDQMAEYVSRLDDGDETKLRGLASPVSSGDGSSNGTFFR
AVLLVRRAKYDEAREYVERARKCLATELAALVLESYERAYSNMVRVQQLSELEERIQGSK
RNVEVWQALLAVRALVLPPTEDVETWLKFASLCRKSGRISQAKSTLLKLLPFDPEVSPEN
MQYHGPPQVMLGYLKYQWSLGEERKRKEAFTKLQILTRELSSVPHSQSDILASMVSSKGA
NVPLLARVNLKLGTWQWALSSGLNDGSIQEIRDAFDKSTCYAPKWAKAWHTWALFNTAVM
SHYISRGQIASQYVVSAVTGYFYSIACAANAKGVDDSLQDILRLLTLWFNHGATADVQTA
LKTGFSHVNINTWLVVLPQIIARIHSNNRAVRELIQSLLIRIGENHPQALMYPLLVACKS
ISNLRRAAAQEVVDKVRQHSGALVDQAQLVSHELIRVAILWHEMWHEALEEASRLYFGEH
NIEGMLKVLEPLHDMLDEGVKKDSTTIQERAFIEAYRHELKEAHECCCNYKITGKDAELT
QAWDLYYHVFKRIDKQLASLTTLDLESVSPELLLCRDLELAVPGTYRADAPVVTISSFSR
QLVVITSKQRPRKLTIHGNDGEDYAFLLKGHEDLRQDERVMQLFGLVNTLLENSRKTAEK
DLSIQRYSVIPLSPNSGLIGWVPNCDTLHHLIREHRDARKIILNQENKHMLSFAPDYDNL
PLIAKVEVFEYALENTEGNDLSRVLWLKSRSSEVWLERRTNYTRSLAVMSMVGYILGLGD
RHPSNLMLHRYSGKILHIDFGDCFEASMNREKFPEKVPFRLTRMLVKAMEVSGIEGNFRS
TCENVMQVLRTNKDSVMAMMEAFVHDPLINWRLFNFNEVPQLALLGNNNPNAPADVEPDE
EDEDPADIDLPQPQRSTREKEILQAVNMLGDANEVLNERAVVVMARMSHKLTGRDFSSSA
IPSNPIADHNNLLGGDSHEVEHGLSVKVQVQKLINQATSHENLCQNYVGWCPFW*
>AT1G57600.1 | membrane bound O-acyl transferase (MBOAT) family protein
MNTHNNRYAKWKQRELVLILLYAIAFYAYVVWRSLRLSHDHYFKLHGLASGWLIPNRRND
VSDAQWRNFRGNLPILSFVFAVFTVIANGVRSFFHLRAKGMAILWLSMSLIYLIYLHGAC
VIYILSIATANFLLVKVFARTSYFPYMLWTFNIFFLFCNRIYEGYSFSIFGQQFEFLDNF
RGTFRWHICFNFVVLRMLSFGYDYHWSQLDSHFDQEKHVMRCSLCKLGKTCYVVRQERGL
ASDSCSFSLYLCYLVYAPLYLAGPIISFNAFASQLDMPQNTLSFKDVAWYGVRWLFSFLL
IELMTHLFYYNAFVISGLWRELSPVEIFIVGYGVLNFMWLKFLLLWRYFRFWSLVNGIET
VENMPNCINNCYSLELFWKTWHASFNRWLIRYMYIPLGGSRRKFLNVWVVFTFVAMWHDL
EWKLLSWAWLTCLFFMPEMLLKSASSAYKVESAFGEFLLRELKALSGAVTITCLMIANLA
GYVIGPSGINWMVSSFLKREGVPVLGGVFFSLYVGTKLMFHIQDLRSVAHSPK*
>AT2G34770.1 | FAH1 (FATTY ACID HYDROXYLASE 1) catalytic/ fatty acid alpha-hydroxylase
MVAQGFTVDLKKPLVFQVGHLGEDYEEWVHQPIATKEGPRFFQSDFWEFLTLTVWWAVPV
IWLPVVVWCISRSVSMGCSLPEIVPIVVMGIFIWTFFEYVLHRFVFHIKTKSYWGNTAHY
LIHGCHHKHPMDHLRLVFPPTATAILCFPFWNIAKAISTPSTAPALFGGGMLGYVMYDVT
HYYLHHAQPTRPVTKNLKKYHLNHHFRIQDKGFGITSSLWDIVFGTLPTTKAPRKEQ*
>AT3G06460.1 | GNS1/SUR4 membrane family protein
MASVYSTLTYWLVHHPYIANFTWTEGETLGSTVFFVFVVVSLYLSATFLLRYTVDSLPTL
GPRILKPITAVHSLILFLLSLTMAVGCTLSLISSSDPKARLFDAVCFPLDVKPKGPLFFW
AQVFYLSKILEFVDTLLIILNKSIQRLSFLHVYHHATVVILCYLWLRTRQSMFPVGLVLN
STVHVIMYGYYFLCAIGSRPKWKKLVTNFQMVQFAFGMGLGAAWMLPEHYFGSGCAGIWT
VYFNGVFTASLLALFYNFHSKNYEKTTTSPLYKIESFIFIHGERWANKAITLFSKKND*
>AT3G56640.1 | exocyst complex subunit Sec15-like family protein
MEAKPKRRIVTENGDTGEDLVLATLIGNGDDVGPLVRHAFEMGRPEPLVHQLKNVARKKE
AEIEDLCKTHYEEFIVAVDELRGVLVDAEELKSDLASDNFRLQEVGSALLVKLEELLESY
AVKKNVTEAIKMSKICVQALELCVKCNSYISEGQFYHALKTMDLIEKSYLKLIPLKVLKL
VIERRIPVIKTHIEKKVCSQFNEWLVHIRSSSKNIGQTAIGLTASARQREEEMLERQRRA
EEQNTGGLGELAYTLDVEDSEQDSVLKFDLTPLYRAYHIHTILGVPERFRDYYYENRLLQ
LQSDLQITYTQPFVESYQTFLAQVAGYFIVEDRVIRTAGDFLLADQVETMWETAISKIVA
ILENQFARMDSPTHLLLVKDYVTLLGTTLRQYGYEVGPVLDALDKSRDKYHELLLEECRK
QIVTAITEDTYQQMVIKKEADYENNVLSFNLQTSDIMPAFTYIAPFSSMVPDVCRIIRSY
IKGSVDYLSYGVNTNFFSVLRKYLDKILIDVLNEVILETISNNSIGVSQAMQIAANISFL
EKASDYFLRHAAQLCGIPSRSVERPQASLAAKVVLKTSRDAAYLALLNVVNTKLDEFMKL
TENVNWTTEEMPQGPHEYINEVVIYLETVMSTAQQILPMDALYKVGVGAIEHISNSIVST
FLSDSIKRFNANAVSAINHDLRVIENFADERYHSSGLNEIYKEGSFRSYLVEARQLINLL
SSSQPENFMNPVIRERNYNTLDYKKVATICEKFKDSADGIFGSLANRNTKLTAKKKSMDM
LKKRLKEFN*
>AT4G22540.2 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.2 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.2 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.1 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MRVKELHPLCCITLESPHGINSQSPEEPVTTALTRSRSLPAKSLTGGSESETVAGILYKW
TNFGKGWRSRWFLLRNGILSYSKIRRPENLNLLSPDDDVRLIGDISGERLSRMDSCSGRR
KQQKTVGIVHLKVSSFRESKSDDRKFYIFTATKTLHLRTDSITDRAAWLQALASTKCIFP
LRSLNGDFSFIPPKDLSISTERLKKRLHEEGMNENLVKECEQIMLSEFSEMHGQVKLLHE
ERTNLLDALRQLEAANLEVGASGKHEFSSLGRGKYSECSTTASSDGKQEFEDVSEEDEPS
FHDTKEFFNEPNIGSESNLAISGHTDIKRRTKLPDPAEKEKGVSLWSMIKDNVGKDLTRV
CLPVYFNEPISSLQKCFEDLEYSYLLDRAYEHGKSGNGLLRALNVAAFAVSGYASTEGRH
CKPFNPLLGETYEADFPEKGIRFFSEKVSHHPTVIACHCEGKGWKFWGDTNLRSKFWGRS
IQVEPVGVLTLEFDDGEVFQWSKVTSTIYNIILGKLYCDHHGVMQIRGNRQYSCTLKFKE
QSILERNPHQVNGFVEDVAGQKAATIFGKWDDSLYYVAGDGINKSKVSDPASNASLLWKR
TKPPPNVTRYNLTSFAITLNELTPGLQEILPPTDSRLRPDQRHLENGEYEKANLEKQRLE
RRQRMSRQLQESGWRPRWFERQGESDTFKYTGGYWEARGHRNWDDCPDIFGEFTEELADA
A*
>AT4G22540.1 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MRVKELHPLCCITLESPHGINSQSPEEPVTTALTRSRSLPAKSLTGGSESETVAGILYKW
TNFGKGWRSRWFLLRNGILSYSKIRRPENLNLLSPDDDVRLIGDISGERLSRMDSCSGRR
KQQKTVGIVHLKVSSFRESKSDDRKFYIFTATKTLHLRTDSITDRAAWLQALASTKCIFP
LRSLNGDFSFIPPKDLSISTERLKKRLHEEGMNENLVKECEQIMLSEFSEMHGQVKLLHE
ERTNLLDALRQLEAANLEVGASGKHEFSSLGRGKYSECSTTASSDGKQEFEDVSEEDEPS
FHDTKEFFNEPNIGSESNLAISGHTDIKRRTKLPDPAEKEKGVSLWSMIKDNVGKDLTRV
CLPVYFNEPISSLQKCFEDLEYSYLLDRAYEHGKSGNGLLRALNVAAFAVSGYASTEGRH
CKPFNPLLGETYEADFPEKGIRFFSEKVSHHPTVIACHCEGKGWKFWGDTNLRSKFWGRS
IQVEPVGVLTLEFDDGEVFQWSKVTSTIYNIILGKLYCDHHGVMQIRGNRQYSCTLKFKE
QSILERNPHQVNGFVEDVAGQKAATIFGKWDDSLYYVAGDGINKSKVSDPASNASLLWKR
TKPPPNVTRYNLTSFAITLNELTPGLQEILPPTDSRLRPDQRHLENGEYEKANLEKQRLE
RRQRMSRQLQESGWRPRWFERQGESDTFKYTGGYWEARGHRNWDDCPDIFGEFTEELADA
A*
>AT4G22540.1 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MRVKELHPLCCITLESPHGINSQSPEEPVTTALTRSRSLPAKSLTGGSESETVAGILYKW
TNFGKGWRSRWFLLRNGILSYSKIRRPENLNLLSPDDDVRLIGDISGERLSRMDSCSGRR
KQQKTVGIVHLKVSSFRESKSDDRKFYIFTATKTLHLRTDSITDRAAWLQALASTKCIFP
LRSLNGDFSFIPPKDLSISTERLKKRLHEEGMNENLVKECEQIMLSEFSEMHGQVKLLHE
ERTNLLDALRQLEAANLEVGASGKHEFSSLGRGKYSECSTTASSDGKQEFEDVSEEDEPS
FHDTKEFFNEPNIGSESNLAISGHTDIKRRTKLPDPAEKEKGVSLWSMIKDNVGKDLTRV
CLPVYFNEPISSLQKCFEDLEYSYLLDRAYEHGKSGNGLLRALNVAAFAVSGYASTEGRH
CKPFNPLLGETYEADFPEKGIRFFSEKVSHHPTVIACHCEGKGWKFWGDTNLRSKFWGRS
IQVEPVGVLTLEFDDGEVFQWSKVTSTIYNIILGKLYCDHHGVMQIRGNRQYSCTLKFKE
QSILERNPHQVNGFVEDVAGQKAATIFGKWDDSLYYVAGDGINKSKVSDPASNASLLWKR
TKPPPNVTRYNLTSFAITLNELTPGLQEILPPTDSRLRPDQRHLENGEYEKANLEKQRLE
RRQRMSRQLQESGWRPRWFERQGESDTFKYTGGYWEARGHRNWDDCPDIFGEFTEELADA
A*
>AT4G22540.3 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.3 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.3 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT5G13150.1 | ATEXO70C1 (exocyst subunit EXO70 family protein C1) protein binding
MEKSGNHHHANESSENHDHKSEDHENKQHSDELHSSTPESQSESSEHSLVEVMEAVVDFI
QTLSSEKDPLGEISPAVESFPEAVDSLVSKMESSGLGRDETEDSVFIDAVNRISKSVMRL
RELKLDSTPVSSWLNRASSVQHRAVSLLDEEFRHLLDRSREEEKKNNNNNNHHDGSNSDH
NNSSTNDSDRCVLQDHEEAEEESFHDFSPESISTLKKIAGAMISAGYEAECCMSYEMSRR
HAFKEELTEVGFEGINVEDVQRIGWESLEGEIASWISIVRRCSTVLFPGELSLCNAVFPD
QDHSSVRKRLFTGLVSAVTIRFLDFSGAVVLTKRSSEKLFKFLDMYETLRDLIPAVEQSD
SDLIQEIKLAQTRLGEAAVTIFGELEKSIKSDNGRTPVPSGAVHPLTRYTMNYLKYACEY
KETLDQVFQHYEANQTDNKPEPETKPRQQQREDDEEYKVSAFARQMIRVMELLDANLEIK
SRLYRDPSLRFIFLMNNGRYILQKIKGSIEIRDLMGQSWTRKRSTELRQYHKSYQRETWG
KVLQCMNQEGLQVNGKVSKPVLKERFKIFNAMFDEIHKTQSTWIVSDEQMQSELRVSISS
LVIPAYRSFFGRYKQHLDSGKQTDKYVKYQPEDIESFIDDLFDGNPTSMARKR*
>AT5G42000.1 | ORMDL family protein
MYVRALPTTDVNRNTEWFTYPGVWTTYILILFFSWLLVLSVFHCSPGIAWTIVHLAHFTV
TYHSFHWKKGTPFGDDQGVYNRLTWWEQIDNGKQLTRNRKFLTVVPVVLYLIASHTTDYQ
HPMLFLNTLAVFVMVVAKFPHMHKVRIFGINGDQ*
>AT5G42000.1 | ORMDL family protein
MYVRALPTTDVNRNTEWFTYPGVWTTYILILFFSWLLVLSVFHCSPGIAWTIVHLAHFTV
TYHSFHWKKGTPFGDDQGVYNRLTWWEQIDNGKQLTRNRKFLTVVPVVLYLIASHTTDYQ
HPMLFLNTLAVFVMVVAKFPHMHKVRIFGINGDQ*
>AT5G42000.2 | ORMDL family protein
MYVRALPTTDVNRNTEWFTYPGVWTTYILILFFSWLLVLSVFHCSPGIAWTIVHLAHFTV
TYHSFHWKKGTPFGDDQGVYNRLTWWEQIDNGKQLTRNRKFLTVVPVVL*
>AT5G42000.2 | ORMDL family protein
MYVRALPTTDVNRNTEWFTYPGVWTTYILILFFSWLLVLSVFHCSPGIAWTIVHLAHFTV
TYHSFHWKKGTPFGDDQGVYNRLTWWEQIDNGKQLTRNRKFLTVVPVVL*
>AT5G45900.1 | APG7 (AUTOPHAGY 7) APG8 activating enzyme
MAEKETPAIILQFAPLNSSVDEGFWHSFSSLKLDKLGIDDSPISITGFYGPCGHPQVSNH
LTLLSESLPLDEQSLIASTSHGNRNKCPVPGILYNTNTVESFNKLDKQSLLKAEANKIWE
DIQSGKALEDPSVLPRFLVISFADLKKWSFRYWFAFPAFVLDPPVSLIELKPASEYFSSE
EAESVSAACNDWRDSDLTTDVPFFLVSVSSDSKASIRHLKDLEACQGDHQKLLFGFYDPC
HLPSNPGWPLRNYLALIRSRWNLETVWFFCYRESRGFADLNLSLVGQASITLSSGESAET
VPNSVGWELNKGKRVPRSISLANSMDPTRLAVSAVDLNLKLMRWRALPSLNLNVLSSVKC
LLLGAGTLGCQVARTLMGWGIRNITFVDYGKVAMSNPVRQSLYNFEDCLGRGEFKAVAAV
KSLKQIFPAMETSGVVMAIPMPGHPISSQEEDSVLGDCKRLSELIESHDAVFLLTDTRES
RWLPSLLCANANKIAINAALGFDSYMVMRHGAGPTSLSDDMQNLDINKTNTQRLGCYFCN
DVVAPQDSMTDRTLDQQCTVTRPGLAPIAGALAVELLVGVLQHPLGINAKGDNSSLSNTG
NNDDSPLGILPHQIRGSVSQFSQITLLGQASNSCTACSETVISEYRERGNSFILEAINHP
TYLEDLTGLTELKKAANSFNLDWEDDDTDDDDVAVDL*